ENGLBERGER WERNER GUENTER,SUNDERMANN BERND,HENNIES HAGEN-HEINRICH,MAUL CORINNA,BUSCHMANN HELMUT HEINRICH,GERMANN TIENO,HOLENZ JORG
申请号：
NO20035730
公开号：
NO332217B1
申请日:
2003.12.19
申请国别(地区):
NO
年份:
2012
代理人:
摘要：
The invention is directed to physiologically active compounds of general formula (I): and compositions containing such compounds； and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.Sammendrag Det er beskrevet substituerte l-oksa-2,8-diazaspiro[4.5]dec-en-derivater av generell formel (I) samt fremgangsmåte for deres fremstilling, deres anvendelse for fremstilling av legemidler og legemidler inneholdende disse forbindelsene.
